Next-Generation Respiratory Gas Analysis Platform

Publication ID: 24-11857310_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Respiratory Gas Analysis Platform,” Published Technical Disclosure No. 24-11857310_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857310_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,310.

Summary of the Inventive Concept

A cutting-edge physiological parameter processing apparatus integrating AI, machine learning, and cloud-based analytics to revolutionize respiratory disorder diagnosis and personalized therapy.

Background and Problem Solved

The original patent, Physiological parameter processing apparatus, had limitations in its ability to predict respiratory disorders and provide personalized recommendations. The present inventive concept addresses these limitations by incorporating advanced analytics and AI-driven decision support, enabling real-time monitoring, and personalized therapy for respiratory disorders.

Detailed Description of the Inventive Concept

The next-generation platform comprises a neural network-based analyzer, a machine learning algorithm, and a cloud-based data analytics module. The analyzer is trained on a dataset of respiratory gas patterns associated with various respiratory disorders, enabling accurate prediction and diagnosis. The machine learning algorithm identifies patterns indicative of sleep apnea and other respiratory disorders. The cloud-based module stores and analyzes data from multiple subjects, providing insights into patterns and trends. The platform also includes a wearable apparatus for real-time monitoring and a wireless communication module for transmitting data to the cloud. The AI-driven decision support system provides personalized recommendations for respiratory therapy based on a subject's respiratory gas data and medical history.

Novelty and Inventive Step

The new claims introduce a paradigm shift in respiratory gas analysis by incorporating AI, machine learning, and cloud-based analytics, which are not obvious extensions of the original patent. The neural network-based analyzer, machine learning algorithm, and AI-driven decision support system are novel and non-obvious features that enable real-time monitoring, personalized therapy, and accurate diagnosis of respiratory disorders.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, integration with existing electronic health records, or the development of specialized wearable devices for specific respiratory disorders. Variations of the platform could also include the use of edge computing or fog computing for real-time analysis and reduced latency.

Potential Commercial Applications and Market

The next-generation respiratory gas analysis platform has significant commercial potential in the healthcare industry, particularly in the fields of respiratory medicine, sleep disorder diagnosis, and personalized therapy. The platform could be marketed to hospitals, clinics, and healthcare providers, as well as to patients and consumers seeking advanced respiratory monitoring and therapy solutions.

Original Patent Information

Patent NumberUS 11,857,310
TitlePhysiological parameter processing apparatus
Assignee(s)NIHON KOHDEN CORPORATION